- Home
- SCYX vs LDTC Comparison
SCYX vs LDTC Comparison
Compare SCYX & LDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCYX
- LDTC
- Stock Information
- Founded
- SCYX 1999
- LDTC 2007
- Country
- SCYX United States
- LDTC Canada
- Employees
- SCYX N/A
- LDTC N/A
- Industry
- SCYX Biotechnology: Pharmaceutical Preparations
- LDTC Blank Checks
- Sector
- SCYX Health Care
- LDTC Finance
- Exchange
- SCYX Nasdaq
- LDTC Nasdaq
- Market Cap
- SCYX 40.9M
- LDTC 37.5M
- IPO Year
- SCYX 2014
- LDTC N/A
- Fundamental
- Price
- SCYX $0.90
- LDTC $0.39
- Analyst Decision
- SCYX
- LDTC Buy
- Analyst Count
- SCYX 0
- LDTC 2
- Target Price
- SCYX N/A
- LDTC $3.00
- AVG Volume (30 Days)
- SCYX 94.5K
- LDTC 113.3K
- Earning Date
- SCYX 05-07-2025
- LDTC 05-13-2025
- Dividend Yield
- SCYX N/A
- LDTC N/A
- EPS Growth
- SCYX N/A
- LDTC N/A
- EPS
- SCYX N/A
- LDTC N/A
- Revenue
- SCYX $3,746,000.00
- LDTC $331,997.00
- Revenue This Year
- SCYX $460.12
- LDTC $906.25
- Revenue Next Year
- SCYX $253.87
- LDTC $149.88
- P/E Ratio
- SCYX N/A
- LDTC N/A
- Revenue Growth
- SCYX N/A
- LDTC 141.86
- 52 Week Low
- SCYX $0.73
- LDTC $0.22
- 52 Week High
- SCYX $3.07
- LDTC $2.75
- Technical
- Relative Strength Index (RSI)
- SCYX 45.97
- LDTC 39.81
- Support Level
- SCYX $0.89
- LDTC $0.36
- Resistance Level
- SCYX $0.99
- LDTC $0.42
- Average True Range (ATR)
- SCYX 0.08
- LDTC 0.06
- MACD
- SCYX 0.01
- LDTC 0.00
- Stochastic Oscillator
- SCYX 64.71
- LDTC 44.16
About SCYX SCYNEXIS Inc.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.